ClinConnect ClinConnect Logo
Search / Trial NCT05370391

Comprehensive Behavioral Intervention for Tics

Launched by UNIVERSITY OF MIAMI · May 6, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Comprehensive Behavioral Intervention for Tics (CBIT) for young people with tic disorders, such as Tourette's Syndrome or other similar conditions. The goal is to see how well this treatment works and to learn more about what factors might influence its success. The trial is currently recruiting participants aged 18 to 26 years and is open to all genders. To be eligible, individuals must have a diagnosed tic disorder or show signs of tic symptoms that cause significant difficulties in daily life. It's important that participants can speak and read English and have a parent or caregiver who can help with consent and questionnaires.

If you or someone you know is considering participating, you can expect to undergo assessments and complete surveys to help researchers understand the impact of the treatment. However, individuals with certain conditions, such as severe mental health issues or those currently receiving other forms of therapy, may not be eligible. The trial allows participants who are on specific psychiatric medications, as long as they do not require a break from their medication for the study. This research could provide valuable insights into effective ways to support young people dealing with tic disorders.

Gender

ALL

Eligibility criteria

  • Inclusion criteria
  • A current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Tic disorder (e.g., Tourette's Disorder/syndrome, Persistent (Chronic) Motor or Vocal Tic Disorder, or Provisional Tic Disorder) or caregiver/youth report of clinically impairing tic symptoms
  • Ability for youth to speak/read English sufficiently
  • At least one parent/caregiver available to sign study consent forms, remain present during assessments, and fill out study questionnaires in English.
  • Exclusion criteria
  • A current diagnosis of psychosis, bipolar disorder, intellectual disability, acute suicidality, alcohol/substance dependence, or eating disorder.
  • Youth currently receiving psychotherapy elsewhere and/or have previously received CBIT.
  • Currently suicidal or who have engaged in suicidal behaviors within the past 6 months will be excluded
  • Youth currently taking psychotropic medication for a co-morbid psychiatric illness will be included without a wash-out period (to not delay treatment).

About University Of Miami

The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.

Locations

Coral Gables, Florida, United States

Patients applied

0 patients applied

Trial Officials

Jill Ehrenreich-May, Ph.D.

Study Director

University of Miami

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials